Novozymes A/S (CPH:NSIS.B)
Denmark · Delayed Price · Currency is DKK 459.20
+1.50 (0.33%)
Nov 4, 2026, 5:00 PM CET
Novozymes Revenue
Novozymes had revenue of 1.12B EUR in the quarter ending June 30, 2026, with 9.59% growth. This brings the company's total for the last twelve months to 4.30B, up 4.86% year-over-year. In the year 2025, Novozymes had annual revenue of 4.16B with 8.45% growth. That makes Novozymes the 2,712th largest company in the world by revenue and 12th in Denmark.
Revenue (ttm)
4.30B EUR
Revenue Growth
+4.86%
P/S Ratio
6.66
Revenue / Employee
381.51K EUR
Employees
11,263
Market Cap
213.95B DKK
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Novozymes breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.16B | 324.10M | 8.45% |
| Dec 31, 2024 | 3.83B | 1.43B | 59.58% |
| Dec 31, 2023 | 2.40B | 46.92M | 1.99% |
| Dec 31, 2022 | 2.36B | 344.63M | 17.14% |
| Dec 31, 2021 | 2.01B | 122.03M | 6.46% |
| Dec 31, 2020 | 1.89B | -34.05M | -1.77% |
| Dec 31, 2019 | 1.92B | -455.38K | -0.02% |
| Dec 31, 2018 | 1.92B | -28.45M | -1.46% |
| Dec 31, 2017 | 1.95B | 44.03M | 2.31% |
| Dec 31, 2016 | 1.91B | 28.53M | 1.52% |
| Dec 31, 2015 | 1.88B | 204.34M | 12.20% |
| Dec 31, 2014 | 1.67B | 99.58M | 6.32% |
| Dec 31, 2013 | 1.58B | 69.01M | 4.58% |
| Dec 31, 2012 | 1.51B | 92.11M | 6.51% |
| Dec 31, 2011 | 1.41B | 109.59M | 8.40% |
| Dec 31, 2010 | 1.30B | 166.75M | 14.66% |
| Dec 31, 2009 | 1.14B | 44.95M | 4.11% |
| Dec 31, 2008 | 1.09B | 92.14M | 9.21% |
| Dec 31, 2007 | 1.00B | 88.28M | 9.68% |
| Dec 31, 2006 | 912.26M | 70.85M | 8.42% |
| Dec 31, 2005 | 841.41M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| A.P. Møller - Mærsk | 368.19B |
| DSV A/S | 299.49B |
| Vestas Wind Systems | 151.75B |
| Carlsberg | 90.29B |
| Ørsted | 83.67B |
| Danske Bank | 58.99B |
| Tryg A/S | 43.66B |
| Coloplast | 28.94B |
Novozymes News
- 7 weeks ago - Novonesis price target raised to DKK 540 from DKK 520 at JPMorgan - TheFly
- 2 months ago - Novonesis price target raised to DKK 500 from DKK 422 at Berenberg - TheFly
- 2 months ago - Novonesis price target raised to DKK 535 from DKK 520 at Morgan Stanley - TheFly
- 2 months ago - Novozymes Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Novozymes Quarterly report: Q2 2026 - Filings
- 2 months ago - Novozymes Slides: Q2 2026 - Filings
- 3 months ago - Novonesis price target raised to DKK 520 from DKK 500 at JPMorgan - TheFly
- 4 months ago - Novonesis upgraded to Neutral from Underperform at BNP Paribas - TheFly